Investing.com - Bio-Techne (NASDAQ: TECH) reported third quarter EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $289.5M versus the consensus estimate of $280.22M.
Bio-Techne's stock price closed at $70.74. It is down -11.76% in the last 3 months and up 29.49% in the last 12 months.
Bio-Techne saw 0 positive EPS revisions and 7 negative EPS revisions in the last 90 days. See Bio-Techne's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Techne's Financial Health score is "good performance".
Check out Bio-Techne's recent earnings performance, and Bio-Techne's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar